Cite
HARVARD Citation
Vyas, C. et al. (2021). Multicentre, randomised clinical trial comparing intravitreal aflibercept monotherapy versus aflibercept combined with reduced-fluence photodynamic therapy (RF-PDT) for the treatment of polypoidal choroidal vasculopathy. BMJ open. 11 (7), p. . [Online].